Gujarat Ambuja Exports has officially commenced commercial production at its new manufacturing facility in Hubli, Karnataka. The company announced that commercial operations began on December 19, 2025, at approximately 9:45 a.m., marking a significant operational milestone in India's specialty chemicals sector.

Plant Specifications and Technology

The newly operational facility brings cutting-edge manufacturing capabilities to the Indian market with several key features:

The facility utilizes maize starch fermentation technology, making it the first plant of its kind in India. This technological advancement positions Gujarat Ambuja Exports at the forefront of specialty chemical manufacturing in the country.

Expansion Strategy and Future Plans

Gujarat Ambuja Exports has outlined an ambitious growth trajectory for the Hubli facility. The company plans to significantly expand the plant's production capacity through strategic scaling:

The company aims to introduce additional products in the maize fermentation-based segment, demonstrating confidence in market demand and commitment to scaling operations.

Regulatory Compliance and Strategic Significance

The commencement announcement was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, highlighting the strategic importance of this development. The plant's operational status represents several key advantages:

• Introduction of first-of-its-kind maize starch fermentation technology in India
• Strategic expansion into specialty chemicals market
• Establishment of manufacturing presence in Karnataka
• Foundation for substantial capacity growth through 2028

The facility marks the beginning of a new chapter for Gujarat Ambuja Exports in the specialty chemicals sector, with sodium gluconate production serving as a key growth driver for the company's diversification strategy in maize fermentation-based products.

Gujarat Ambuja Exports Limited (GAEL) has released its financial results for the second quarter, revealing a mixed performance with revenue growth but a decline in profitability.

Revenue Growth

The company reported a significant increase in revenue, which rose to 14.87 billion rupees in Q2, up from 11.25 billion rupees in the same period last year. This represents a year-over-year growth of approximately 32.2%, indicating strong top-line performance.

Profit Decline

Despite the revenue growth, GAEL experienced a substantial decrease in net profit. The company's net profit for the quarter stood at 380.8 million rupees, down from 695 million rupees in the corresponding quarter of the previous year. This marks a decline of about 45.2% in net profit.

EBITDA and Margin Compression

The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) also saw a decrease:

The EBITDA margin compressed significantly from 9.79% to 5.10%, indicating pressure on the company's operational efficiency.

Management Appointments

In a separate announcement, GAEL's Board of Directors approved the appointment of three new Additional Directors in the category of Non-Executive & Independent Directors, each for a term of five consecutive years, subject to shareholder approval:

1. Mr. Dukhabandhu Rath (DIN: 08965826)
2. Mr. Yogesh Ghanshyambhai Shah (DIN: 11203883)
3. Ms. Gauri Trivedi (DIN: 06502788)

These appointments may bring fresh perspectives and expertise to the company's board.

Conclusion

While Gujarat Ambuja Exports Limited has shown strong revenue growth in the second quarter, the decline in profitability and margin compression suggest challenges in maintaining cost efficiency. Investors and stakeholders will likely be watching closely to see how the company addresses these issues and leverages its revenue growth to improve bottom-line performance in the coming quarters.

The addition of new independent directors to the board may also signal the company's commitment to strengthening its corporate governance and bringing in diverse expertise to navigate the current business environment.